COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Fluidigm Announces Agreement with DNA Software to Offer Secondary CNV Analysis for Biomark HD04/10/2018
-   
  ALAVIDA champions self-expression and promotes “Drink Less, Your Way” campaign04/10/2018
-   
  Wildflower Sees 300% Growth in Online Sales This Year04/10/2018
-   
  IntelGenx Partner Insud Pharma Submits ANDA for Co-Developed Generic Buccal Film Product04/10/2018
-   
  OV - Oncology Venture receives authority clearance to expand an ongoing Phase 2 study of LiPlaCis by inclusion of prostate cancer patients04/10/2018
-   
  Monmouth County Plastic Surgeon Announces the Opening of State-of-the-Art Facility in Wall, New Jersey04/10/2018
-   
  LONG ISLAND PLASTIC SURGICAL RESIDENTS PRESENT AT THE AMERICAN SOCIETY OF PLASTIC SURGEON’S ANNUAL MEETING IN CHICAGO04/10/2018
-   
  Parkinson’s Institute and Clinical Center and Retrotope Announce Collaboration on New Drug Treatment Therapies for Parkinson’s Disease Patients04/10/2018
-   
  Establishment Labs Announces Transition to a Direct Sales Force in Germany and Spain During its 4th Annual World Symposium on Ergonomic Implants04/10/2018
-   
  GBT Announces Upcoming Presentations at National Sickle Cell Disease Association of America (SCDAA) Convention04/10/2018
-   
  Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC Published in European Radiology04/10/2018
-   
  Momenta Pharmaceuticals to Host R&D Day on October 11, 201804/10/2018
-   
  AMAG Pharmaceuticals and Endoceutics Announce Presentation at the 2018 Annual Meeting of The North American Menopause Society on the Effect of Time Since Menopause, Age and Previous Hormone Therapy on the Response to Intravaginal Prasterone04/10/2018
-   
  BIOMODEX Announces New Training Solution for Left Atrial Appendage Closure (LAACS)04/10/2018
-   
  Tauriga Sciences Inc. Enters into MOU to Acquire California Based Revenue Generating OMEGA-3 Product and Technology04/10/2018
-   
  Pain Therapeutics Announces $3.5 Million NIH Grant Award to Study Alzheimer’s Disease04/10/2018
-   
  SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox04/10/2018
-   
  Integrated Cannabis Company, Inc. Announces Positive Results from Clinical Study of X-SPRAYS Sleep Product04/10/2018
-   
  Study Opens of BeyondSpring’s Lead Asset, Plinabulin, and Nivolumab + Ipilimumab in Small-Cell Lung Cancer04/10/2018
Pages